SEARCH

SEARCH BY CITATION

References

  • Alloueche A, Bailey W, Barton S et al. (2004) Comparison of chlorproguanil–dapsone with sulfadoxine–pyrimethamine for the treatment of uncomplicated falciparum malaria in young African children: double-blind randomised controlled trial. The Lancet 363, 18431848.
  • Berglez J, Iliades P, Sirawaraporn W, Coloe P & Macreadie I (2004) Analysis in Escherichia coli of Plasmodium falciparum dihydropteroate synthase (DHPS) alleles implicated in resistance to sulfadoxine. International Journal for Parasitology 34, 95100.
  • Biswas S (2004) Associations of antifolate resistance in vitro and point mutations in dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum. Journal of Postgraduate Medicine 50, 1720.
  • Brockelman CR, Tan-ariya P, Piankijagum A & Matangkasombut P (1983) An in vitro approach to study innate resistance to Plasmodium falciparum infection in folic acid deficient individuals. Asian Pacific Journal of Allergy and Immunology 1, 107111.
  • Carter JY, Loolpapit MP, Lema OE et al. (2005) Reduction of the efficacy of antifolate antimalarial therapy by folic acid supplementation. American Journal of Tropical Medicine and Hygiene 73, 166170.
  • Chulay JD, Watkins WM & Sixsmith DG (1984) Synergistic antimalarial activity of pyrimethamine and sulfadoxine against Plasmodium falciparumin vitro. American Journal of Tropical Medicine and Hygiene 33, 325330.
  • Dieckmann A & Jung A (1986) Mechanisms of sulfadoxine resistance in Plasmodium falciparum. Molecular and Biochemical Parasitology 19, 143147.
  • Donno L & Sanguineti V (1970) Therapy of natural falciparum malaria with combinations of antifolic drugs in non-immune subjects. Chemotherapy 15, 118124.
  • Dzinjalamala FK, Macheso A, Kublin JG et al. (2005) Blood folate concentrations and in vivo sulfadoxine–pyrimethamine failure in Malawian children with uncomplicated Plasmodium falciparum malaria. American Journal of Tropical Medicine and Hygiene 72, 267272.
  • Greene LS (1999) Genetic and dietary adaptation to malaria in human populations. Parassitologia 41, 185192.
  • Iliades P, Berglez J, Meshnick S & Macreadie I (2003) Promoter strength of folic acid synthesis genes affects sulfa drug resistance in Saccharomyces cerevisiae. Microbial Drug Resistance 9, 249255.
  • Khalil I, Alifrangis M, Ronn AM et al. (2002) Pyrimethamine/sulfadoxine combination in the treatment of uncomplicated falciparum malaria: relation between dihydropteroate synthase/dihydrofolate reductase genotypes, sulfadoxine plasma levels, and treatment outcome. American Journal of Tropical Medicine and Hygiene 67, 225229.
  • Mberu EK, Nzila AM, Nduati E et al. (2002) Plasmodium falciparum: in vitro activity of sulfadoxine and dapsone in field isolates from Kenya: point mutations in dihydropteroate synthase may not be the only determinants in sulfa resistance. Experimental Parasitology 101, 9096.
  • Milhous WK, Weatherly NF, Bowdre JH & Desjardins RE (1985) In vitro activities of and mechanisms of resistance to antifol antimalarial drugs. Antimicrobial Agents and Chemotherapy 27, 525530.
  • Ndounga M, Basco LK & Ringwald P (2001) Evaluation of a new sulfadoxine sensitivity assay in vitro for field isolates of Plasmodium falciparum. Transactions of the Royal Society of Tropical Medicine and Hygiene 95, 5557.
  • Price RN & Nosten F (2001) Drug resistant falciparum malaria: clinical consequences and strategies for prevention. Drug Resistance Updates 4, 187196.
  • Tan-ariya P & Brockelman CR (1983a) Continuous cultivation and improved drug responsiveness of Plasmodium falciparum in p-aminobenzoic acid-deficient medium. Journal of Parasitology 69, 353359.
  • Tan-ariya P & Brockelman CR (1983b) Plasmodium falciparum: variations in p-aminobenzoic acid requirements as related to sulfadoxine sensitivity. Experimental Parasitology 55, 364371.
  • Tan-ariya P, Brockelman CR & Menabandhu C (1987) Optimal concentration of p-aminobenzoic acid and folic acid in the in vitro assay of antifolates against Plasmodium falciparum. American Journal of Tropical Medicine and Hygiene 37, 4248.
  • Terlouw DJ, Courval JM, Kolczak MS et al. (2003) Treatment history and treatment dose are important determinants of sulfadoxine–pyrimethamine efficacy in children with uncomplicated malaria in Western Kenya. Journal of Infectious Diseases 187, 467476.
  • Then RL (1982) Mechanisms of resistance to trimethoprim, the sulfonamides, and trimethoprim–sulfamethoxazole. Reviews of Infectious Diseases 4, 261269.
  • Triglia T & Cowman AF (1999) Plasmodium falciparum: a homologue of p-aminobenzoic acid synthetase. Experimental Parasitology 92, 154158.
  • Triglia T, Menting JG, Wilson C & Cowman AF (1997) Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum. Proceedings of the National Academy of Sciences of the United States of America 94, 1394413949.
  • Triglia T, Wang P, Sims PF, Hyde JE & Cowman AF (1998) Allelic exchange at the endogenous genomic locus in Plasmodium falciparum proves the role of dihydropteroate synthase in sulfadoxine-resistant malaria. EMBO Journal 17, 38073815.
  • Wang P, Brobey RK, Horii T, Sims PF & Hyde JE (1999) Utilization of exogenous folate in the human malaria parasite Plasmodium falciparum and its critical role in antifolate drug synergy. Molecular Microbiology 32, 12541262.
  • Wang P, Nirmalan N, Wang Q, Sims PF & Hyde JE (2004a) Genetic and metabolic analysis of folate salvage in the human malaria parasite Plasmodium falciparum. Molecular and Biochemical Parasitology 135, 7787.
  • Wang P, Wang Q, Aspinall TV, Sims PF & Hyde JE (2004b) Transfection studies to explore essential folate metabolism and antifolate drug synergy in the human malaria parasite Plasmodium falciparum. Molecular Microbiology 51, 14251438.
  • Watkins WM, Sixsmith DG, Chulay JD & Spencer HC (1985) Antagonism of sulfadoxine and pyrimethamine antimalarial activity in vitro by p-aminobenzoic acid, p-aminobenzoylglutamic acid and folic acid. Molecular and Biochemical Parasitology 14, 5561.